Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Debarshi Kar Mahapatra"'
Publikováno v:
Journal of Critical Reviews. :1-5
Gout is a common form of arthritis characterized by severe and sudden pain for a long duration, swelling, tenderness, lingering discomfort, and acute redness in the joint situated at the big toe due to the accumulation of monosodium urate (MSU) cryst
Autor:
Ruchi S Shivhare, Ashwini Ingole, Jagdish R. Baheti, Debarshi Kar Mahapatra, Manish A. Kamble
Publikováno v:
Journal of Drug Delivery and Therapeutics. 8:106-110
DEET based mosquito repellents were found to be comparatively harmful to the person suffering from urea cycle disorders such as ornithine transcarbamylase (OTD) deficiency and, are therefore, contraindicated in individuals. These situations lead to t
Gout is a form of an arthritic syndrome characterized by severe chronic pain, discomfort, swelling, and redness in the joint present in the big toe as a result of monosodium urate (MSU) crystals accumulation. This chapter focuses on the ability of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7760bfbd2adaf1b027ce4d2ef718eb29
https://doi.org/10.1201/9781003003229-9
https://doi.org/10.1201/9781003003229-9
Publikováno v:
Expert Opinion on Therapeutic Patents. 27:887-906
The RAS/RAF/MEK/ERK and PI3K/AKT/mTOR signaling pathways have been identified as promising therapeutic targets for cancer therapy. Over-activation of these pathways and their components including gene mutations has been considered as one of the major
Publikováno v:
European Journal of Medicinal Chemistry. 125:299-314
The discovery of genetic, genomic and clinical biomarkers have revolutionized the treatment option in the form of personalized medicine which allows to accurately predict a person's susceptibility/progression of disease, the patient's response to the
Publikováno v:
European Journal of Medicinal Chemistry. 92:839-865
Diabetes Mellitus (DM) is the fastest growing metabolic disorder affecting about 387 million people across the globe and is estimated to affect 592 million people by year 2030. The search for newer anti-diabetic agents is the foremost need to control
Publikováno v:
ChemInform. 46
Diabetes Mellitus (DM) is the fastest growing metabolic disorder affecting about 387 million people across the globe and is estimated to affect 592 million people by year 2030. The search for newer anti-diabetic agents is the foremost need to control